Lately, Hollywood superstars Angelina Jolie and Brad Pitt’s rumored obsession with Dysport injection—a newly FDA-approved wrinkle treatment—has become one of the hottest topics online.
What does FDA say about the new age-defying treatment anyway? Well, at least for now, this anti-wrinkle technology, sold under the trade name Dysport, has so far secured the FDA’s approval. The approval came amid rumors that the injectable treatment is made with the same neurotoxin used in making botox, particularly the botulinum toxin type A, Wrinkles.org wrote in a report.
According to showbiz website Celebrity Laundry, the Hollywood couple’s rumored obsession with botox has raised concern among fans. This, after reports claim that the obsession is starting to ruin the couple’s appearance, and the couples are now trying to cover up their blemishes with fillers.
It wasn’t really sure whether the two have been using botox or any form of plastic surgery, as the couple isn’t keen on talking about the cosmetic procedures they undergo. In the same way, the couple hasn’t been directly rejecting rumors claiming that they’ve been seeking major dermatologic procedures lately.
Meanwhile, in a statement, Ipsen, maker of Dysport, has announced the recent FDA-approval of the abobotulinumtoxinA for Injection for the treatment of Lower Limb Spasticity (LLA) in Children aged two and above. The pharmaceutical company boasted that it is the first and only, so far, FDA-approved botulinum toxin in the U.S.
“This approval in the US is a milestone in the treatment of pediatric lower limb spasticity, a condition that greatly impacts both children two years of age and older living with this form of spasticity and their caregivers. Dysport® is the first and only botulinum toxin approved by the FDA for this indication,” said Claude Bertrand, Executive Vice President, Research and Development, Chief Scientific Officer, Ipsen in the statement.